Marketresearch.biz reports that the Global Achondroplasia Market size is expected to be worth around USD 1,189.8 Million by 2033, from USD 70.6 Million in 2024, growing at a CAGR of 33.60% during the ...

Developmental milestones help us understand when a child needs help, but meeting them early doesn’t necessarily predict ...

Jason Zemansky, an analyst from Bank of America Securities, maintained the Buy rating on BridgeBio Pharma (BBIO – Research Report). The ...

In a report released today, Jack Allen from Robert W. Baird downgraded BioMarin Pharmaceutical (BMRN – Research Report) to a Hold, with a ...

By Mary de Wet BioMarin Pharmaceutical will discontinue certain research and development programs and cut about 170 jobs as part of its strategic ...

U.S. para badminton player Miles Krajewski feels a sense of redemption after punching his ticket to the Paralympics in Paris ...

Savarirayan and his colleagues found similar results 6 in people with another type of dwarfism called achondroplasia. “It was just really interesting when I looked at this paper and saw a lot of ...

In PEOPLE's exclusive clip, Liz explains that she wants to emulate her mother, Amber, and welcome a baby boy for her first ...

UPDATED: Bristol Myers cutting $1.5B in costs in less than 2 years, with 2,200 employees impacted in 2024 Voxzogo snagged FDA approval in achondroplasia—a genetic disorder that impairs bone ...

VOXZOGO in achondroplasia continues towards blockbuster status. The majority of new U.S. prescriptions in the quarter were for children under the age of 5, an important trend since FDA's age ...